FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088528 [Registered on: 10/06/2025] Trial Registered Prospectively
Last Modified On: 09/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Healing with Different Sutures After Wisdom Tooth Removal  
Scientific Title of Study   Comparative evaluation of hyaluronic acid impregnated mersilk, conventional mersilk and vicryl plus sutures following mandibular third molar surgery. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Amit B. Lall 
Designation  JUNIOR RESIDENT 1 
Affiliation  SANTOSH DEEMED TO BE UNIVERSITY 
Address  DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY, SANTOSH DENTAL COLLEGE AND HOSPITAL, SANTOSH DEEMED TO BE UNIVERSITY, GHAZIABAD
K-64, K BLOCK, SECTOR-12, PRATAP VIHAR, GHAZIABAD
Ghaziabad
UTTAR PRADESH
201009
India 
Phone  98910007011  
Fax    
Email  dr_abl@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Amit B. Lall 
Designation  JUNIOR RESIDENT 1 
Affiliation  SANTOSH DEEMED TO BE UNIVERSITY 
Address  DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY, SANTOSH DENTAL COLLEGE AND HOSPITAL, SANTOSH DEEMED TO BE UNIVERSITY, GHAZIABAD
K-64, K BLOCK, SECTOR-12, PRATAP VIHAR, GHAZIABAD
Ghaziabad
UTTAR PRADESH
201009
India 
Phone  9810007011  
Fax    
Email  abl_yahoo@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Amit B. Lall 
Designation  JUNIOR RESIDENT 1 
Affiliation  SANTOSH DEEMED TO BE UNIVERSITY 
Address  DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY, SANTOSH DENTAL COLLEGE AND HOSPITAL, SANTOSH DEEMED TO BE UNIVERSITY, GHAZIABAD
K-64, K BLOCK, SECTOR-12, PRATAP VIHAR, GHAZIABAD
Ghaziabad
UTTAR PRADESH
201009
India 
Phone  98910007011  
Fax    
Email  dr_abl@yahoo.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY, SANTOSH DENTAL COLLEGE AND HOSPITAL, SANTOSH DEEMED TO BE UNIVERSITY, GHAZIABAD 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shraddha Sonwane  Santosh Dental College and Hospital, Ghaziabad, Uttar Pradesh   Department of Oral and Maxillofacial Surgery, Santosh dental college, Santosh deemed to be university, Santosh nagar, sector 12, Block K, Pratap vihar, Ghaziabad, Uttarpradesh,201009.
Ghaziabad
UTTAR PRADESH 
9869134018

shraddhasonwane511@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee of Santosh deemed to be university  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  patients with ASA I and II requiring intraoral incisions and impacted third molar extraction 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Conventional mersilk and vicryl plus sutures  closure will involve the usage of Conventional mersilk and vicryl plus suture to achieve hemostasis. 
Comparator Agent  Hyaluronic acid impregnated mersilk suture  Following incision and 3rd molar extraction after achieving hemostasis, closure will involve HA impregnated 3-0 mersilk suture material within 10-20 minutes post surgery. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  -Participants within the age group of 18 to 50 years.
-Patients requiring surgical removal of mandibular third molars.
-Willingness to comply with the postoperative care instructions and follow-up visits.  
 
ExclusionCriteria 
Details  • Current use of medications known to affect wound healing, including corticosteroids or immunosuppressants.
• Patients not willing to participate in the study.
• Medically compromised like having diabetes, hypertension, pregnant females and anxious patients.
• Patients with a history of allergy to anesthetics or acute inflammation at the surgical site.
• Patients with existing oral infections or pericoronitis.
• Known allergy to local anesthetics or suture materials.  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
A. Clinical Parameters
-Landry’s Healing Index (3rd and 7th day)
-Visual Analog Scale for pain and discomfort
-Clinician-rated suture handling and removal
B. Microbiological Parameters
Total CFU count on blood agar, chocolate agar, MacConkey agar
Bacterial species identification (e.g., Streptococcus, Lactobacillus) 
Post- operative day 1st, 3rd and 7th. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Mandibular third molar extraction is a common oral surgical procedure frequently associated with postoperative complications such as pain, edema, trismus, hematoma, prolonged bleeding, pyrexia, and alveolar osteitis. These adverse effects can delay recovery and increase the risk of secondary infections and chronic pain. Sutures are critical in promoting wound stability and healing. This single-blinded, randomized controlled clinical trial aims to evaluate the efficacy of 1.5% hyaluronic acid (HA)-impregnated 3-0 mersilk sutures compared to conventional 3-0 mersilk and 3-0 Vicryl Plus sutures in mandibular third molar surgery. A total of 84 extraction sites will be randomly allocated into three equal groups (n=28): HA-impregnated mersilk (Group I), vicryl Plus (Group II), and conventional mersilk (Group III). Randomization will be conducted via coin flip, and outcome assessment will be blinded. Clinical wound healing will be evaluated using Landry’s Healing Index on postoperative days 1, 3, and 7. Microbial colonization will be assessed by colony-forming unit (CFU) counts, and pain levels will be measured using the Visual Analog Scale (VAS).The study hypothesizes that HA-impregnated mersilk sutures will demonstrate superior outcomes in wound healing, microbial control, and pain reduction. HA’s anti-inflammatory and antimicrobial properties may enhance tissue regeneration and minimize postoperative complications, potentially improving patient recovery and overall clinical outcomes.

 
Close